De Novo Human Cardiac Myocytes for Medical Research: Promises and Challenges

The advent of cellular reprogramming technology has revolutionized biomedical research. De novo human cardiac myocytes can now be obtained from direct reprogramming of somatic cells (such as fibroblasts), from induced pluripotent stem cells (iPSCs, which are reprogrammed from somatic cells), and fro...

Descripción completa

Detalles Bibliográficos
Autores principales: Hamel, Veronique, Cheng, Kang, Liao, Shudan, Lu, Aizhu, Zheng, Yong, Chen, Yawen, Xie, Yucai, Liang, Wenbin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2017
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5337883/
https://www.ncbi.nlm.nih.gov/pubmed/28303153
http://dx.doi.org/10.1155/2017/4528941

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5337883/
https://www.ncbi.nlm.nih.gov/pubmed/28303153
http://dx.doi.org/10.1155/2017/4528941

Ejemplares similares